DEUTSCHE BANK AG\ - MARKER THERAPEUTICS INC ownership

MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 71 filers reported holding MARKER THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of MARKER THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$45,000
+45.2%
19,972
-8.5%
0.00%
Q4 2020$31,000
+6.9%
21,820
+14.4%
0.00%
Q3 2020$29,000
-14.7%
19,070
+16.0%
0.00%
Q2 2020$34,000
-38.2%
16,446
-43.1%
0.00%
Q1 2020$55,000
-49.5%
28,908
-24.8%
0.00%
Q4 2019$109,000
+179.5%
38,439
+381.2%
0.00%
Q3 2019$39,000
-77.1%
7,988
-63.1%
0.00%
Q2 2019$170,00021,6680.00%
Other shareholders
MARKER THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Aisling Capital Management LP 2,000,000$4,140,0001.58%
NEA Management Company, LLC 5,000,000$10,350,0000.42%
Vigilare Wealth Management 103,450$214,0000.22%
Riggs Asset Managment Co. Inc. 37,500$77,0000.03%
WEDBUSH SECURITIES INC 110,174$228,0000.02%
GSA CAPITAL PARTNERS LLP 18,450$38,0000.02%
MERIDIAN MANAGEMENT CO 17,812$37,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 223,216$462,0000.01%
NEVILLE RODIE & SHAW INC 30,101$62,0000.01%
Ascent Wealth Partners, LLC 10,273$21,0000.01%
View complete list of MARKER THERAPEUTICS INC shareholders